Study guide
Pneumonitis, Extravasation, and Local Therapy Emergencies
OCN Oncology Certified Nurse Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: OCN Exam Orientation and Official Source Control
Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness
2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care
Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures
3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment
Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation
4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards
Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development
5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy
Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation
6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents
Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation
7 Chapter 7: Symptom Management and Supportive Care
Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination
8 Chapter 8: Oncologic Emergencies and Rapid Escalation
Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage
9 Chapter 9: Psychosocial Dimensions of Oncology Care
Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals
10 Chapter 10: Mixed OCN Case Labs
New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab
11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness
Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning
Pneumonitis, Extravasation, and Local Therapy Emergencies
Key Takeaways Explain This Topic AI
New cough, dyspnea, hypoxia, or declining exercise tolerance during cancer therapy demands prompt evaluation for pneumonitis, infection, pulmonary embolism, or progression.
Immune-checkpoint-inhibitor pneumonitis can be fatal and is treated by holding therapy and starting high-dose corticosteroids, not antibiotics alone.
Extravasation is a time-critical local emergency: stop the infusion immediately, leave the catheter in place, aspirate residual drug, and apply the drug-specific warm or cold compress.
Antidote and compress choice is agent-specific: anthracycline extravasation uses dexrazoxane with cold compresses, while vinca alkaloid extravasation uses hyaluronidase with warm compresses.
Radiation and procedural complications include airway edema, severe esophagitis, hemorrhage, perforation, and pneumothorax, and may evolve over hours to days after the patient leaves.
Last updated: October 2026
Pneumonitis, Extravasation, and Local Therapy Emergencies
Not every emergency is systemic. Some begin in the lungs, a vein, a radiation field, or a procedure site. The RN's job is to catch the pattern early and keep small injuries from becoming respiratory failure, tissue necrosis, hemorrhage, or permanent functional loss.
Pneumonitis
Pneumonitis is inflammation of lung tissue caused by immune checkpoint inhibitors, targeted therapies (e.g., EGFR inhibitors, mTOR inhibitors), antibody-drug conjugates, bleomycin, radiation, or infection. Symptoms include new or worsening cough, dyspnea, chest tightness, fever, fatigue, hypoxia, and reduced activity tolerance, and it mimics pneumonia, PE, heart failure, and disease progression.
- Respiratory finding Nursing concern
- New dry cough during immunotherapy Possible immune-related pneumonitis
- Dyspnea with hypoxia Urgent evaluation and oxygen support
- Fever plus productive cough Infection, pneumonitis, or both
- Pleuritic pain Consider PE or infection
- Rapidly rising oxygen need Emergency response and possible transfer
A crucial OCN point: checkpoint-inhibitor pneumonitis is treated by holding the drug and giving high-dose corticosteroids , not antibiotics alone, and it can be fatal. Nursing actions: vitals, continuous pulse oximetry, lung auscultation, activity tolerance, infection screening, oxygen as indicated, and prompt provider notification. Reinforce that patients must not self-start leftover antibiotics or steroids.
Extravasation
Extravasation is leakage of a drug into surrounding tissue. Vesicants cause blistering, necrosis, and tendon or nerve injury; irritants cause pain or inflammation without necrosis. Early signs: burning, stinging, pain, swelling, erythema, blanching, coolness, loss of blood return, resistance to flushing, or a slowed infusion.
When extravasation is suspected, stop the infusion immediately but leave the catheter in place initially - you may need to aspirate residual drug or instill antidote through it. Disconnect tubing, aspirate if directed, notify the provider, mark and measure the area, photograph per policy, and elevate the limb. The compress and antidote are agent-specific , a classic OCN test point:
- Vesicant class Compress Antidote
- Anthracyclines (doxorubicin) Cold Dexrazoxane (or topical DMSO)
- Vinca alkaloids (vincristine) Warm Hyaluronidase
- Mechlorethamine Cold Sodium thiosulfate
Mnemonic: anthracyclines like it cold, vinca alkaloids like it warm. Never apply heat or cold randomly - the wrong choice can worsen injury. Document the drug, concentration, estimated volume, site, symptoms, interventions, response, education, and follow-up plan.
Radiation and Procedure Emergencies
Radiation emergencies include airway edema after head-and-neck treatment, severe esophagitis with dehydration, radiation pneumonitis, moist skin desquamation with infection, hemorrhagic cystitis, and radiation enteritis. Surgical and interventional complications include hemorrhage, wound dehiscence, perforation, bile leak, urinary obstruction, pneumothorax after thoracentesis or biopsy, and embolization complications. Monitor for pain out of proportion to the procedure, fever, drainage, swelling, crepitus, dyspnea, hypotension, tachycardia, and new neurologic deficits.
Education and Follow-Up After Local Injury
Local therapy emergencies need active follow-up because damage evolves after the patient leaves the chair, scanner, or operating room. For pneumonitis, ask whether the patient can speak in full sentences, climb their usual stairs, sleep flat, and maintain their baseline oxygen saturation. For extravasation, give site-specific instructions and schedule follow-up calls, warning the patient that tissue injury can worsen over days with increasing pain, blistering, numbness, reduced movement, or spreading redness. For procedure sites, compare pain and drainage against discharge instructions and assess anticoagulant use.
Teach patients to call for new shortness of breath, persistent cough, fever, chest pain, a painful or blistering infusion site, spreading redness, wound opening, uncontrolled pain, or bleeding, and use teach-back with a clear contact number before discharge.
Grading and Why Mechanism-Aware Care Matters
For both pneumonitis and extravasation, severity grading drives the response. Pneumonitis is commonly graded by symptoms and oxygen needs: grade 1 is asymptomatic radiographic change, grade 2 brings symptoms limiting daily activities, and grade 3 to 4 brings severe symptoms or hypoxia requiring hospitalization, oxygen, and high-dose corticosteroids with the offending drug held; checkpoint inhibitors are permanently discontinued for grade 3 to 4 pneumonitis. Distinguishing immune pneumonitis from infection and embolism matters because treating the wrong cause - antibiotics alone for an immune process, or steroids alone for a bacterial pneumonia - lets the patient deteriorate.
For extravasation , the harm depends entirely on whether the agent is a vesicant or an irritant and on which specific vesicant it is, which is why the warm-versus-cold and antidote choices are agent-specific rather than generic. Applying cold to a vinca alkaloid or warm to an anthracycline can deepen the injury, so the nurse confirms the drug and consults the protocol before applying anything.
A worked example: a patient on continuous vincristine through a peripheral line develops swelling and loss of blood return - the nurse stops the infusion, leaves the catheter for aspiration, applies a warm compress, anticipates hyaluronidase , elevates the limb, photographs and measures the site, and arranges follow-up because tissue damage can evolve for days. Precise, mechanism-aware nursing is what separates a recoverable infiltration from a disabling tissue loss.
Prevention is part of the standard: confirm a brisk blood return and a patent vein before infusing any vesicant, prefer a central line for high-risk continuous vesicants such as continuous anthracyclines or vinca alkaloids, never use a peripheral line that has had multiple recent attempts in the same vein, and stay with the patient during the initial vesicant push so a problem is caught in seconds rather than minutes. Teach patients to report any burning, stinging, or new pain at the site immediately rather than assuming it is normal, because their early report is often the first sign of leakage.